Israel’s Health Ministry found the small number of heart inflammation cases observed mainly in young men who received Pfizer’s Covid-19 vaccine in Israel were likely linked to the company’s vaccination.
Moderna is gearing up to halve the dose of the company’s Covid-19 vaccine, the U.S. drugmaker said on June 2, so that it can also be used to combat variants and inoculate children.
Moderna Inc. said on June 1 the company had entered into an agreement with Thermo Fisher Scientific for manufacturing and packaging its Covid-19 vaccine, as the U.S. vaccine maker looks to scale up production.
The World Health Organization said on June 1 it has approved a Covid-19 vaccine made by drugmaker Sinovac Biotech for emergency use listing, paving the way for a second Chinese shot to be used in poor countries.
Moderna Inc. on June 1 filed for full U.S. approval of the company’s Covid-19 vaccine, becoming the second drugmaker to do so after Pfizer Inc. and its German partner BioNTech SE sought full clearance for their vaccine in May.
A deal on an intellectual property waiver for Covid-19 vaccines at the World Trade Organization (WTO) was no closer to acceptance on May 31 despite Washington’s backing, due to expected scepticism about a new draft, sources close to the talks told Reuters.
India will have nearly 120 million doses of Covid-19 vaccines available for domestic use in June, the government said on May 30.
The Russian health ministry’s ethical committee declined to approve clinical trials in Russia combining a British shot from AstraZeneca and Oxford University with Russia’s Sputnik V vaccine, an AstraZeneca official told Reuters on May 28.
Europe’s medicines regulator on May 28 backed the use of Pfizer’s Covid-19 vaccine for children as young as 12, paving way for a broader roll-out in the region after similar clearances in the United States and Canada.
France’s Sanofi and Britain’s GlaxoSmithKline launched a late-stage human trial for a recombinant Covid-19 vaccine candidate on May 27 which they hope to get approved by the end of 2021.